These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9744493)

  • 1. Effect of tamoxifen and transdermal hormone replacement therapy on cardiovascular risk factors in a prevention trial. Italian Chemoprevention Group.
    Decensi A; Robertson C; Rotmensz N; Severi G; Maisonneuve P; Sacchini V; Boyle P; Costa A; Veronesi U
    Br J Cancer; 1998 Sep; 78(5):572-8. PubMed ID: 9744493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of tamoxifen and estrogen replacement therapy on lipid metabolism and some other cardiovascular risk factors. A prospective study in hysterectomised women].
    Imperato F; Marziani R; Perniola G; Ebano V; Fruscella M; Mossa B
    Minerva Ginecol; 2003 Feb; 55(1):87-93. PubMed ID: 12598849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of tamoxifen and hormone replacement therapy on serum cholesterol, bone mineral density and coagulation factors in healthy postmenopausal women participating in a randomised, controlled tamoxifen prevention study.
    Chang J; Powles TJ; Ashley SE; Gregory RK; Tidy VA; Treleaven JG; Singh R
    Ann Oncol; 1996 Sep; 7(7):671-5. PubMed ID: 8905024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of hormone replacement therapy and route of administration on selected cardiovascular risk factors in post-menopausal women.
    Seed M; Sands RH; McLaren M; Kirk G; Darko D
    Fam Pract; 2000 Dec; 17(6):497-507. PubMed ID: 11120722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of conjugated equine estrogen in combination with two different progestogens on the risk factors of coronary heart disease in postmenopausal Chinese women in Taiwan: a randomized one-year study.
    Chang TC; Lien YR; Chen M; Cheng SP; Chen RJ; Chow SN
    Acta Obstet Gynecol Scand; 2004 Jul; 83(7):661-6. PubMed ID: 15225192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptoms.
    Sestak I; Kealy R; Edwards R; Forbes J; Cuzick J
    J Clin Oncol; 2006 Aug; 24(24):3991-6. PubMed ID: 16921052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative assessment of lipid effects of endocrine therapy for breast cancer: implications for cardiovascular disease prevention in postmenopausal women.
    Esteva FJ; Hortobagyi GN
    Breast; 2006 Jun; 15(3):301-12. PubMed ID: 16230014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Administration of long-term tamoxifen therapy modifies the plasma lipoprotein-lipid concentration and lipid transfer protein I activity in postmenopausal women with breast cancer.
    Wasan KM; Ramaswamy M; Haley J; Dunn BP
    J Pharm Sci; 1997 Jul; 86(7):876-9. PubMed ID: 9232532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Italian breast cancer prevention trial with tamoxifen: findings and new perspectives.
    Guerrieri-Gonzaga A; Galli A; Rotmensz N; Decensi A
    Ann N Y Acad Sci; 2001 Dec; 949():113-22. PubMed ID: 11795343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of dietary intervention alone or combined with hormone replacement therapy in postmenopausal women with hypercholesterolemia in Seoul, Korea.
    Jung K; Kim S; Woo J; Chang Y
    Eur J Nutr; 2002 Jun; 41(3):101-7. PubMed ID: 12111046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of postmenopausal hormone replacement therapy on insulin resistance.
    Saglam K; Polat Z; Yilmaz MI; Gulec M; Akinci SB
    Endocrine; 2002 Aug; 18(3):211-4. PubMed ID: 12450311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of exemestane on the lipidemic profile of postmenopausal early breast cancer patients: preliminary results of the TEAM Greek sub-study.
    Markopoulos C; Polychronis A; Zobolas V; Xepapadakis G; Papadiamantis J; Koukouras D; Lappas H; Gogas H
    Breast Cancer Res Treat; 2005 Sep; 93(1):61-6. PubMed ID: 16184460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of hormonal replacement therapy on lipid and haemostatic factors in post-menopausal ESRD patients.
    Park JS; Jung HH; Yang WS; Kim SB; Min WK; Chi HS
    Nephrol Dial Transplant; 2000 Nov; 15(11):1835-40. PubMed ID: 11071974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of raloxifene and continuous combined hormone replacement therapy on biochemical markers of cardiovascular risk: results from the Euralox 1 study.
    Nickelsen T; Creatsas G; Rechberger T; Depypere H; Erenus M; Quail D; Arndt T; Bonnar J;
    Climacteric; 2001 Dec; 4(4):320-31. PubMed ID: 11770189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of hormone replacement therapy on blood serum lipids in postmenopausal women with type 2 diabetes].
    Kozlov SG; Dotsenko IuV; Sankova AV; Liakishev AA; Tvorogova MG; Afanas'eva OI; Titov VN; Pokrovskiĭ SN; Naumov VG
    Kardiologiia; 2002; 42(7):47-52. PubMed ID: 12494113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral but not transdermal estrogen replacement therapy changes the composition of plasma lipoproteins.
    Vrablik M; Fait T; Kovar J; Poledne R; Ceska R
    Metabolism; 2008 Aug; 57(8):1088-92. PubMed ID: 18640386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differing effects of low-dose estrogen-progestin therapy and pravastatin in postmenopausal hypercholesterolemic women.
    Davis SR; Goldstat R; Newman A; Berry K; Burger HG; Meredith I; Koch K
    Climacteric; 2002 Dec; 5(4):341-50. PubMed ID: 12626213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal Therapy and Chemoprevention.
    Bonanni B; Guerrieri-Gonzaga A; Rotmensz N; Torrisi R; Pigatto F; Cazzaniga M; Mora S; Diani S; Robertson C; Decensi A
    Breast J; 2000 Oct; 6(5):317-323. PubMed ID: 11348390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
    Araújo DA; Farias ML; Andrade AT
    Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of simvastatin only or in combination with continuous combined hormone replacement therapy on lipid levels in hypercholesterolemic women].
    Dobrzycka B; Dobrzycki S; Lenczewski A; Terlikowski S; Kulikowski M
    Ginekol Pol; 2003 Sep; 74(9):937-42. PubMed ID: 14674148
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.